Serum HER2 extracellular domain (ECD) correlates with HER2 status by immunohistochemistry (IHC) and fluorescent in-situ hybridization (FISH) in metastatic breast cancer (MBC) patients (pts) treated with weekly (W) trastuzumab (H) and paclitaxel (T) Meeting Abstract

  

Authors:	Fornier, M. N.; Seidman, A. D.; Schwartz, M. K.; Panageas, K. S.; Norton, L.; Hudis, C. A.
Abstract Title:	Serum HER2 extracellular domain (ECD) correlates with HER2 status by immunohistochemistry (IHC) and fluorescent in-situ hybridization (FISH) in metastatic breast cancer (MBC) patients (pts) treated with weekly (W) trastuzumab (H) and paclitaxel (T)
Meeting Title:	25th Annual San Antonio Breast Cancer Symposium (SABCS)
Journal Title:	Breast Cancer Research and Treatment
Volume:	76
Issue:	Suppl. 1
Meeting Dates:	2002 Dec 11-14
Meeting Location:	San Antonio, TX
ISSN:	0167-6806
Publisher:	Springer
Date Published:	2002-12-01
Start Page:	S110
Language:	English
ACCESSION:	WOS:000179770100325
PROVIDER:	wos
DOI:	10.1023/A:1021560101414
PUBMED:	12516550
Notes:	Meeting Abstract: 428 -- 25th San Antonio Breast Cancer Symposium -- DEC 11-14, 2002 -- SAN ANTONIO, TEXAS -- 1 -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/71732